QOF Income

QOF financial modelling

QOF Income 2026/27

Indicative QOF income from published achievement, registered lists and disease registers, with each practice's history and a guide to how the money is worked out.

Indicative estimates.Not payment statements. The prevalence factor is reconstructed from published data; CQRS rebases the statutory one against a range that is not published, and payment also depends on CQRS's own data and declarations.

Practice and years

Select a practice

Indicator Explorer — Understand your QOF indicators

Explore indicator definitions, achievement thresholds, available points and the data behind the financial estimates.

Read-only indicator analysis · Use Income Opportunities to model changes The calculator beside an indicator opens it in Income Opportunities.

Indicator reference

Choose a practice above to estimate its income. Until then each indicator is shown for a practice of exactly national-average size (CPI 1), before prevalence adjustment: points × £227.95.

IndicatorDescriptionPointsThresholdsPrevalence adjustmentAt national average
AF006Clinical
Patients with atrial fibrillation in whom stroke risk has been assessed using CHA2DS2-VASc in the preceding 12 months (excluding those with a previous score of 2 or more). Show full wording
12 40-95% adjusted by its disease register £2,735.40
BP002Public Health
Patients aged 45 or over who have a record of blood pressure in the preceding 5 years. Show full wording
15 50-90% not prevalence-adjusted (statute) £3,419.25
AF008Clinical
Patients on the AF register with CHA2DS2-VASc score of 2 or more, prescribed a DOAC or, if unsuitable/declined, a Vitamin K antagonist. Show full wording
12 70-95% adjusted by its disease register £2,735.40
SMOK002Public Health
Patients with specified long-term conditions whose notes record smoking status in the preceding 12 months. Show full wording
25 50-90% combined register not published: no factor £5,698.75
CHD005Clinical
Patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken. Show full wording
7 56-96% adjusted by its disease register £1,595.65
SMOK004Public Health
Patients aged 15 or over recorded as current smokers who have a record of offer of support and treatment within the preceding 24 months. Show full wording
12 40-90% not prevalence-adjusted (statute) £2,735.40
CD001Clinical
Patients with CHD, stroke or TIA, aged 79 years or under, without moderate or severe frailty, whose last BP in the preceding 12 months is 140/90 mmHg or less (or equivalent home BP). Show full wording
41 40-90% combined register not published: no factor £9,345.95
VI001Public Health
Babies reaching 8 months in the preceding 12 months who received at least 3 doses of a diphtheria, tetanus and pertussis containing vaccine before age 8 months. Show full wording
18 89-96% (or improvement 5-18 percentage points) not prevalence-adjusted (statute) £4,103.10
CD002Clinical
Patients with CHD, stroke or TIA, aged 80 years or over, without moderate or severe frailty, whose last BP in the preceding 12 months is 150/90 mmHg or less (or equivalent home BP). Show full wording
20 46-90% combined register not published: no factor £4,559.00
VI002Public Health
Children reaching 18 months in the preceding 12 months who received at least 1 dose of MMR or MMRV between ages 12 and 18 months. Show full wording
18 86-96% (or improvement 5-23 percentage points) not prevalence-adjusted (statute) £4,103.10
CHOL003Clinical
Patients on the CHD, PAD, Stroke/TIA or CKD register currently prescribed a statin or, if declined/unsuitable, another lipid-lowering therapy. Show full wording
20 70-95% combined register not published: no factor £4,559.00
VI003Public Health
Children reaching 5 years in the preceding 12 months who received a second dose of MMR or MMRV before age 5 years. Show full wording
18 81-96% (or improvement 5-30 percentage points) not prevalence-adjusted (statute) £4,103.10
CHOL004Clinical
Patients on the CHD, PAD or Stroke/TIA register with most recent cholesterol in the preceding 12 months at target (LDL ≤2.0 or non-HDL ≤2.6 mmol/L). Show full wording
44 20-50% combined register not published: no factor £10,029.80
VI004Public Health
Patients who reached 80 years old in the preceding 12 months who have received shingles vaccine between ages 70 and 79 years. Show full wording
10 50-60% not prevalence-adjusted (statute) £2,279.50
HF008Clinical
Patients with heart failure diagnosed on or after 1 April 2023, confirmed appropriately by echocardiogram or specialist assessment. Show full wording
6 50-90% adjusted by its disease register £1,367.70
OB004Public Health
Adults living with obesity referred to a weight management programme in the QOF year. Show full wording
5 10-30% adjusted by its disease register £1,139.75
HF007Clinical
Patients with heart failure on the register who have had a review in the preceding 12 months including functional capacity and medication review. Show full wording
7 50-90% adjusted by its disease register £1,595.65
OB005Public Health
Adults living with obesity eligible for shared decision-making and pharmacotherapy pathway support. Show full wording
13 50-80% adjusted by its disease register £2,963.35
CS005Public Health
Women/people with a cervix aged 25–49 with adequate cervical screening test in the previous 3 years and 6 months. Show full wording
7 45-80% target population factor not modelled £1,595.65
HF009Clinical
Patients with HFrEF currently treated with four-pillar therapy: ACEi/ARNI/ARB, beta blocker, MRA and SGLT2 inhibitor. Show full wording
12 20-50% sub-register not held: no factor £2,735.40
CS006Public Health
Women/people with a cervix aged 50–64 with adequate cervical screening test in the previous 5 years and 6 months. Show full wording
4 45-80% target population factor not modelled £911.80
HYP010Clinical
Patients with hypertension aged 79 years or under, without moderate or severe frailty, whose last BP in the preceding 12 months is 140/90 mmHg or less (or equivalent home BP). Show full wording
38 40-85% adjusted by its disease register £8,662.10
HYP011Clinical
Patients with hypertension aged 80 years or over, without moderate or severe frailty, whose last BP in the preceding 12 months is 150/90 mmHg or less (or equivalent home BP). Show full wording
14 40-85% adjusted by its disease register £3,191.30
STIA007Clinical
Patients with non-haemorrhagic stroke or history of TIA who have a record in the preceding 12 months that an anti-platelet agent or anti-coagulant is being taken. Show full wording
4 57-97% adjusted by its disease register £911.80
DM006Clinical
Patients with diabetes, on the register, with a diagnosis of nephropathy (clinical proteinuria) or micro-albuminuria who are currently treated with an ACE-I (or ARBs). Show full wording
3 57-97% adjusted by its disease register £683.85
DM014Clinical
Patients newly diagnosed with diabetes who have a record of referral to a structured education programme within 9 months of entry on to the register. Show full wording
11 40-90% adjusted by its disease register £2,507.45
DM020Clinical
Patients with diabetes whose latest IFCC-HbA1c in the preceding 12 months is 58 mmol/mol or less. Show full wording
17 35-75% adjusted by its disease register £3,875.15
DM021Clinical
Patients with diabetes, on the register, with moderate or severe frailty in whom the last IFCC-HbA1c is 75 mmol/mol or less in the preceding 12 months. Show full wording
10 52-92% adjusted by its disease register £2,279.50
DM034Clinical
Patients with diabetes and no CVD currently prescribed a statin, or where clinically unsuitable/declined, another lipid-lowering therapy. Show full wording
8 50-90% adjusted by its disease register £1,823.60
DM035Clinical
Patients with diabetes and established CVD currently prescribed a statin, or where clinically unsuitable/declined, another lipid-lowering therapy. Show full wording
8 50-90% adjusted by its disease register £1,823.60
DM036Clinical
Patients with diabetes, on the register aged 79 years and under, without moderate or severe frailty, whose last BP in the preceding 12 months is 140/90 mmHg or less (or equivalent home BP). Show full wording
27 38-90% adjusted by its disease register £6,154.65
DM037Clinical
Patients with diabetes receiving all eight annual care processes in the preceding 12 months. Show full wording
10 35-75% adjusted by its disease register £2,279.50
AST007Clinical
Patients with asthma on the register who have had an asthma review in the preceding 12 months that includes an assessment of asthma control, a recording of the number of exacerbations, an assessment of inhaler technique and a written personalised action plan. Show full wording
20 45-70% adjusted by its disease register £4,559.00
AST012Clinical
Patients with a new diagnosis of asthma on or after 1 April 2025 with a record of an objective test between 3 months before or 3 months after diagnosis. Show full wording
15 45-80% adjusted by its disease register £3,419.25
COPD010Clinical
Patients with COPD who have had a review in the preceding 12 months including exacerbation count and MRC breathlessness score. Show full wording
9 50-90% adjusted by its disease register £2,051.55
DEM004Clinical
Patients with dementia who have had a face-to-face or remote care plan review in the preceding 12 months. Show full wording
14 35-70% adjusted by its disease register £3,191.30
MH002Clinical
Patients with schizophrenia, bipolar affective disorder and other psychoses with a comprehensive care plan documented in the preceding 12 months. Show full wording
5 40-90% adjusted by its disease register £1,139.75
MH003Clinical
Patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of blood pressure in the preceding 12 months. Show full wording
3 50-90% adjusted by its disease register £683.85
MH006Clinical
Patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of BMI in the preceding 12 months. Show full wording
3 50-90% adjusted by its disease register £683.85
MH007Clinical
Patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of alcohol consumption in the preceding 12 months. Show full wording
3 50-90% adjusted by its disease register £683.85
MH011Clinical
Patients with schizophrenia, bipolar affective disorder and other psychoses with lipids recorded in the preceding 12 months. Show full wording
7 50-90% adjusted by its disease register £1,595.65
MH012Clinical
Patients with schizophrenia, bipolar affective disorder and other psychoses with glucose or HbA1c recorded in the preceding 12 months. Show full wording
7 50-90% adjusted by its disease register £1,595.65
NDH003Clinical
Patients with non-diabetic hyperglycaemia or previous gestational diabetes who have had HbA1c or fasting blood glucose in the preceding 12 months. Show full wording
20 50-90% adjusted by its disease register £4,559.00